Eversept Partners’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.58M Buy
+336,000
New +$1.74M 0.08% 88

Other funds holding UNCY

Eversept Partners's UNCY Position: Q3 2026 in Review

Eversept Partners opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 336,000 shares worth $1.58M. The stake represents 0.08% of the portfolio and ranks #88 among its holdings.

90 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • Eversept Partners held 336,000 shares of Unicycive Therapeutics worth $1.58M as of Q3 2026.
  • Unicycive Therapeutics was a new Eversept Partners position in Q3 2026.
  • Unicycive Therapeutics made up 0.08% of Eversept Partners's portfolio in Q3 2026, its #88 holding.
  • 90 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.